Justin Olshavsky

General Partner, Bio+Health Fund

2023 - Current

Founding GP of Pioneer Fund's Bio+Health focused fund. Investing in pre-seed and seed stage biotechnology, life science, and healthcare companies. Please reach out if you're building in bio+health!

Entrepreneur-in-Residence

2021 - 2022

Focus on Bio+Health

Venture Partner

2020 - 2021

Venture Partner - 10/2020-01/2021 Senior Venture Partner - 01/2021-11/2021

Building

2023

Pressing pause on biological time.

Entrepreneur-in-Residence

2024

Neuroprotection

2020 - 2023

Transitioning the Voyage technology to Penumbra post-acquisition

Co-founder and CTO

2018 - 2023

Hypothermia to end brain damage from stroke. Y Combinator S19. Voyage was acquired by Penumbra (NYSE:PEN)

Robotics Engineer

2017 - 2018

Bomb-disposal robots, robotic systems for satellites

Biomechanics Research

2016 - 2016

Simulating artificial heart valves in silico

Mechanical Engineering Intern

2014 - 2014

Nuclear energy